Clinical Trial Update: Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on ST-100 (Vezocolmitide) ophthalmic solution for dry eye disease, reporting on its safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• ST-100 (Vezocolmitide) (Vezocolmitide)

Snippet

Sponsor: ORA, Inc. | Conditions: Dry Eye Disease | Phase 3 | Status: UNKNOWN